Analisis Efektivitas Biaya Penggunaan Antibiotik Pasien Pneumonia Pada Balita di Rumah Sakit Umum Daerah Wangaya

Authors

  • NI KOMANG WIJA KUSUMA WATI MAHASISWA UNIVERSITAS BALI INTERNASIONAL

Keywords:

Kata kunci : Analisis efektivitas biaya, Pneumonia, Antibiotik, Balita

Abstract

ABSTRACT

                   Clinically pneumonia is defined as a inflammation caused by microorganisms (bacteria, viruss, fungi, parasites). Pneumonia that often occurs and is serious is community-acquired pneumonia (CAP). Antibiotics are the mainstay of therapy for CAP which is caused by bacteria. The purpose of this study was to determine the cost-effectiveness analysis of the use of antibiotics for pneumonia patients in children under five year at Wangaya Regional General Hospital. The method in this study is a cross-sectional of patient medical records in 2019. The data collection method in this study is observation. Subjects used in this study were patients diagnosed with pneumonia community acquired pneumonia CAP in children under five year at the Wangaya Regional General Hospital, with antibiotic therapy of ceftriaxone and cefotaxime. The results of this study are that there are differences that significant P 0,05  on mean total cost of treatment between ceftriaxone treatment arm compared to cefotaxime. For effectiveness there was no significant difference P 0,05  in the effectiveness of treatment between the ceftriaxone group and the cefotaxime group. The effectiveness of treatment was seen from the length of stay, duration of antibiotic use and decreased respiration rate. The cefotaxime group was more cost effective than the ceftriaxone group. It is necessary to carry out similar studies in different locations in order to know the comparison of the cost-effectiveness of antibiotic therapy in other areas, thereby increasing reference in the selection of antibiotics that are cost-effective and therapeutic effectiveness.

 

Keywords: Cost-effectiveness analysis, Pneumonia, Antibiotics, Children Under Five Year

References

Amelia, 2018. Alisis Efektivitas Biaya (Cost Effectiveness Analysis) Pengobatan Pneumonia Menggunakan Antibiotik Seftriakson Dan Sefotaksim Di Rsup Prof. Dr. R. D. Kandou Manado. Program Studi Farmasi FMIPA UNSRAT Manado. Jurnal Ilmiah Farmasi, Vol. 7., No. 3.

Andayani, T.M. 2013. Farmakoekonomi Prinsip dan Metodologi. Bursa Ilmu. Yogyakarta.

Binfar. 2011. Pedoman Pelayanan Kefarmasian Untuk Terapi Antibiotik. Penerbit : Kementerian Kesehatan Republik Indonesia. Jakarta.

Binfar. 2013. Pedoman Penerapan Kajian Farmakoekonomi. Penerbit : Kementerian Kesehatan Republik Indonesia. Jakarta.

Brunton L, et al. 2008. Goodman & Gilman : Manual Farmakologi dan Terapi. Terjemahan : Sukanda YE, dkk. Penerbit : Buku Kedokteran EGC. Jakarta.

Charbek, E. 2015. Normal Vital Signs. St Louis University Hospital. http://emedicine.medscape.com/arti cle/2172054-overview

Depkes RI, 2005, Pharmaceutical Care Untuk Infeksi Saluran Pernafasan, Departemen Kesehatan Republik Indonesia, Jakarta.

Didik, S., Dwi, E., Auliya, S. 2014. Farmakoekonomi Modeling. Penerbit : UM Purwokerto-Press. Purwokerto.

Hapsari, B. 2007. Infeksi Respiratorik Bawah Akut pada Anak. Aditya Medika. Yogyakarta.

Hartati,S., Nurhaeni N., dan Gayatri D., 2012, Faktor Risiko Terjadinya Pneumonia pada Anak Balita, VI (15), 13-20

Kado-Kimble. 2008. Applied Therapeutics : The Clinical Use of Drugs. Penerbit : Hil Medical. USA.

Katzung, B.G. 2012. Farmakologi Dasar dan Klinik Edisi 6. Penerbit : EGC. Jakarta

Kemenkes RI. 2013. Riset Kesehatan Dasar Penelitian Dan Pengembangan Kementerian Kesehatan. Republik Indonesia. Jakarta

Kemenkes RI. 2018. Data da Informasi Profil Kesehatan Indonesia 2018. Jakarta

Kementerian Kesehatan Republik Indonesia. 2013. Pedoman Penerapan Kajian Farmakoekonomi. Direktorat Jendral Bina Kefarmasian dan Alat Kesehatan Jakarta

Kementerian Kesehatan Republik Indonesia. Riset kesehatan dasar 2018. Jakarta: Kementerian Kesehatan Republik Indonesia; 2018

Kementerian Kesehatan RI. 2011. Pedoman Pelayanan Kefarmasian Untuk Terapi Antibiotik. Penerbit : Kementrian Republik Indonesia. Jakarta.

Latifatul. 2019. Analisis Efektivitas Biaya Penggunaan Antibiotik Pada Pasien Pneumonia Rawat Inap di RSU Karsa Husada Kota Batu Tahun 2017-2018. Fakultas Kedokteran Dan Ilmu Kesehatan Universitas Islam Negeri Maulana Malik Ibrahim Malang

Lawrence, et., al. 2002. Current Medical Diagnosis & Treatment. Penerbit : University Of California. San Fransisco.

Menteri Kesehatan Republik Indonesia.2014. Peraturan Menteri Kesehatan Republik Indonesia Nomor 27 Tahun 2014 Tentang Petunjuk Teknis Sistem Indonesian Case Base Groups (INA-Cbgs). Jakarta

Meriyani, H. 2015. Efektivitas Terapi Pneumonia pada Pasien Pediatrik di Rumah Sakit Umum Pusat Sanglah Denpasar ditinjau dari Parameter Respiration Rate . Farmasi Saraswati Denpasar. Bali.

Mia.2019.Analisis Efektivitas Biaya Penggunaan Antibiotik pada Pasien Community-acquired Pneumonia di RSUP Dr. Hasan Sadikin Bandung. Fakultas Farmasi, Universitas Padjadjaran, Sumedang, Indonesia. Jurnal Farmasi Klinik Indonesia, September 2019

Nugroho F., Pri I.U. and Ika Y., 2011, Evaluasi Penggunaan Antibiotik Pada Penyakit Pneumonia Di Rumah Sakit Umum Daerah Purbalingga

Nursyafrisda. 2012. Analisis Efektifitas Biaya Penggunaan Ceftriaxone Dan Cefotaxime Pada Pasien Pneumonia Balita Di Rawat Inap Rsu Kab. Tangerang Tahun 2010. Univeristas Indonesia

Orion. 1997. Pharmacoeconomics Primer and Guide Introduction to Economic Evalution. Penerbit : Hoesch Mario Rousell Incorporation. Virginia.

PDPI. 2014. Pneuomonia Komuniti : Pedomana Diagnosis dan Penatalaksanaan di Indonesia. Penerbit : Perhimpunan Dokter Paru Indonesia. Jakarta.

Perhimpunan Dokter Paru Indonesia.2003. Pneumonia Komunitas, pedoman diagnosis & penatalaksanaan di Indonesia. Jakarta: PDPI

Tjiptoherijanto,P.,Soesetyo,B. 1994. Ekonomi Kesehatan.Penerbit. Rineka Cipta Jakarta

Umulsalamah. 2017. Analisis Cost-Effectiveness Penggunaan Antibiotik Pada Pasien Pneumonia Pediatrik Di Instalasi Rawat Inap Rsud Dr. Moewardi Surakarta Tahun 2016. Program Studi Farmasi Fakultas Farmasi Universitas Muhammadiyah Surakarta

UNICEF/WHO. Pneumonia : The Forgotten Killer of Children. Geneva : United Nations Children's Fund/World Health Organization; 2016.

Vogenberg, F.R. 2001. Introduction to Applied Pharmacoeconomics. Penerbit : McGraw-Hill Companies. USA.

Yeni Farida. 2017.Study of Antibiotic Use on Pneumonia Patient in Surakarta Referral Hospital. Jurusan Farmasi Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Sebelas Maret Surakarta

Published

2024-09-01